Literature DB >> 15889903

Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry.

Mireia Urpí-Sardà1, Olga Jáuregui, Rosa Maria Lamuela-Raventós, Walter Jaeger, Michaela Miksits, María-Isabel Covas, Cristina Andres-Lacueva.   

Abstract

In this paper, a sensitive, precise, and selective analytical method has been developed for the identification and quantification of resveratrol metabolites in human low-density lipoprotein (LDL) after moderate consumption of red wine, using high-performance liquid chromatography electrospray in tandem mass spectrometry (LC-ESI-MS/MS). From different extraction procedures tested, solid-phase extraction was selected to minimize matrix effects reaching the highest sensitivity. Standard calibration curves prepared in human LDL for trans-resveratrol were linear over a range of 0.44-438.59 pmol/mL. The accuracy and interassay precision of this LC-MS/MS assay for resveratrol showed a coefficient of variation of <6.0%. The method allows detection and quantification limits for resveratrol in LDL at 0.15 and 0.44 pmol/mL, respectively. Results to date indicate that resveratrol metabolites were incorporated into LDL after a moderate intake of red wine. The metabolites identified in LDL were trans-resveratrol-3-O-glucuronide, cis-resveratrol-3-O-glucuronide, and cis-resveratrol-3-O-glucoside, as well as free trans-resveratrol. To our knowledge, it is the first time that a polyphenol from red wine, specifically resveratrol, has been identified in human LDL after moderate intake of red wine. Furthermore, these findings suggest that these compounds may deliver their antioxidant effect to LDL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889903     DOI: 10.1021/ac0484272

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  14 in total

1.  Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.

Authors:  Miguel Muzzio; Zhihua Huang; Shu-Chieh Hu; William D Johnson; David L McCormick; Izet M Kapetanovic
Journal:  J Pharm Biomed Anal       Date:  2011-10-25       Impact factor: 3.935

Review 2.  Targeting Cancer Via Resveratrol-Loaded Nanoparticles Administration: Focusing on In Vivo Evidence.

Authors:  Ana Cláudia Santos; Irina Pereira; Mariana Magalhães; Miguel Pereira-Silva; Mariana Caldas; Laura Ferreira; Ana Figueiras; António J Ribeiro; Francisco Veiga
Journal:  AAPS J       Date:  2019-04-23       Impact factor: 4.009

Review 3.  High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites.

Authors:  M Holcapek; L Kolárová; M Nobilis
Journal:  Anal Bioanal Chem       Date:  2008-03-15       Impact factor: 4.142

Review 4.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Resveratrol: French paradox revisited.

Authors:  Betul Catalgol; Saime Batirel; Yavuz Taga; Nesrin Kartal Ozer
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

6.  Changes in white adipose tissue metabolism induced by resveratrol in rats.

Authors:  Goiuri Alberdi; Víctor M Rodríguez; Jonatan Miranda; María T Macarulla; Noemí Arias; Cristina Andrés-Lacueva; María P Portillo
Journal:  Nutr Metab (Lond)       Date:  2011-05-10       Impact factor: 4.169

Review 7.  The journey of resveratrol from yeast to human.

Authors:  Silvie Timmers; Johan Auwerx; Patrick Schrauwen
Journal:  Aging (Albany NY)       Date:  2012-03       Impact factor: 5.682

Review 8.  Role of Resveratrol in Prevention and Control of Cardiovascular Disorders and Cardiovascular Complications Related to COVID-19 Disease: Mode of Action and Approaches Explored to Increase Its Bioavailability.

Authors:  Nikola Gligorijević; Dragana Stanić-Vučinić; Mirjana Radomirović; Marija Stojadinović; Urmila Khulal; Olgica Nedić; Tanja Ćirković Veličković
Journal:  Molecules       Date:  2021-05-11       Impact factor: 4.411

Review 9.  Resveratrol in prevention and treatment of common clinical conditions of aging.

Authors:  M Andrea Markus; Brian J Morris
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

Review 10.  Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.

Authors:  J Gambini; M Inglés; G Olaso; R Lopez-Grueso; V Bonet-Costa; L Gimeno-Mallench; C Mas-Bargues; K M Abdelaziz; M C Gomez-Cabrera; J Vina; C Borras
Journal:  Oxid Med Cell Longev       Date:  2015-06-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.